Inventor · disambiguated record
Elizabeth M. Enlow
Also filed as: ENLOW ELIZABETH · ENLOW ELIZABETH M · ENLOW ELIZABETH MARTI
38 granted patents·7 pending applications·180 citations·filing 2009–2023
97Inventor score
Top patents by PatentIndex Score
45 records- 0198US10993908B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2020·Granted May 4, 2021·5 cites·21 claims
- 0298US10940108B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2020·Granted Mar 9, 2021·6 cites·17 claims
- 0398US10857096B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2020·Granted Dec 8, 2020·5 cites·17 claims
- 0498US9056057B2Nanocrystals, compositions, and methods that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2013·Granted Jun 16, 2015·56 cites·28 claims
- 0597US10945948B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2020·Granted Mar 16, 2021·4 cites·21 claims
- 0696US11219597B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2021·Granted Jan 11, 2022·3 cites·30 claims
- 0796US10688045B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2017·Granted Jun 23, 2020·7 cites·91 claims
- 0896US10646437B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2018·Granted May 12, 2020·7 cites·88 claims
- 0996US10646436B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2018·Granted May 12, 2020·7 cites·92 claims
- 1096US9827191B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2013·Granted Nov 28, 2017·13 cites·25 claims
- 1195US9458169B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Oct 4, 2016·22 cites·23 claims
- 1294US11596599B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2021·Granted Mar 7, 2023·2 cites·36 claims
- 1394US9790232B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2015·Granted Oct 17, 2017·12 cites·20 claims
- 1492US10864219B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2018·Granted Dec 15, 2020·5 cites·39 claims
- 1591US10160765B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Dec 25, 2018·7 cites·15 claims
- 1690US12178920B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2023·Granted Dec 31, 2024·0 cites·15 claims
- 1790US10618906B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Apr 14, 2020·2 cites·14 claims
- 1890US10058511B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2017·Granted Aug 28, 2018·2 cites·40 claims
- 1989US11219596B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2021·Granted Jan 11, 2022·1 cites·30 claims
- 2089US9393213B2Nanocrystals, compositions, and methods that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2015·Granted Jul 19, 2016·2 cites·28 claims
- 2187US11872318B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2023·Granted Jan 16, 2024·0 cites·22 claims
- 2287US11642317B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2020·Granted May 9, 2023·1 cites·31 claims
- 2384US12115246B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2023·Granted Oct 15, 2024·0 cites·13 claims
- 2484US9737491B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2016·Granted Aug 22, 2017·1 cites·21 claims
- 2583US9532955B2Nanocrystals, compositions, and methods that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2016·Granted Jan 3, 2017·1 cites·20 claims
- 2682US9688688B2Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Jun 27, 2017·2 cites·16 claims
- 2782US9212145B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Dec 15, 2015·3 cites·80 claims
- 2881US10392388B2Meropenem derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Aug 27, 2019·2 cites·38 claims
- 2979US10736854B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2018·Granted Aug 11, 2020·2 cites·37 claims
- 3076US11713323B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Granted Aug 1, 2023·0 cites·10 claims
- 3174US11091487B2Meropenem derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Aug 17, 2021·0 cites·22 claims
- 3273US10975090B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2020·Granted Apr 13, 2021·0 cites·12 claims
- 3371US2021332048A1Meropenem derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3469US2021052489A1Particles, compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 3567US10875857B21-amino-triazolo(1,5-A)pyridine-substituted urea derivative and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Dec 29, 2020·0 cites·15 claims
- 3667US9393212B2Nanocrystals, compositions, and methods that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2015·Granted Jul 19, 2016·0 cites·31 claims
- 3767US2021087192A11-Amino-triazolo(1,5-A)pyridine-substituted Urea Derivative and Uses ThereofKALA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3862US9725451B2Meropenem derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Aug 8, 2017·0 cites·67 claims
- 3961US10174022B21-amino-triazolo(1,5-A)pyridine-substituted urea derivative and uses thereofKALA PHARMACEUTICALS INC·Filed 2015·Granted Jan 8, 2019·0 cites·9 claims
- 4061US2011264030A1Delivery apparatus and associated methodUNIV NORTH CAROLINA·Filed 2009·Application pending·0 cites
- 4161US2018271782A1Particles, compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2018·Application pending·0 cites
- 4260US2013316006A1Particles, compositions and methods for ophthalmic and/or other applicationsKALA PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 4360US2013316001A1Particles, compositions and methods for ophthalmic and/or other applicationsKALA PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 4450US9890173B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Feb 13, 2018·0 cites·15 claims
- 4539US10253045B2Crystalline forms of a therapeutic compound and uses thereofKALA PHARMACEUTICALS INC·Filed 2015·Granted Apr 9, 2019·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Elizabeth M. Enlow files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →